Abstract:Objectives: The study aimed to evaluate the effectiveness of aztreonam, aztreonam-avibactam, cefiderocol, and cefiderocol-avibactam against numerous New Delhi Metallo-β-Lactamase-producing E. coli isolates, and compare the in vitro activity of these antibiotics against ESBLs, AmpCs, and MBLs-producing isolates of E. coli . Materials and Methods: A total of 57 New Delhi metallo-β-lactamase-producing E.coli were analyzed. Broth microdilution testing was conducted for aztreonam, aztreonam-avibactam, cefiderocol, and cefiderocol-avibactam following the latest EUCAST guidelines. Minimum inhibitory concentrations were determined for each antibiotic using specific broth formulations and concentrations. Molecular typing through Multilocus Sequence Typing was performed to identify the molecular types. Results: Aztreonam-avibactam demonstrated superior in vitro activity compared to aztreonam, cefiderocol, and cefiderocol-avibactam against ESBLs, AmpCs, and metallo-β-Lactamase-producing E. coli isolates. Conclusion: Aztreonam-avibactam exhibited best efficacy against New Delhi Metallo-β-Lactamase-producing E. coli isolates that generate varied New Delhi Metallo-β-Lactamase compared to aztreonam, cefiderocol, and cefiderocol-avibactam. The study highlights the potential of aztreonam-avibactam in overcoming resistance mechanisms observed with other antibiotics, providing valuable insights into the treatment of infections due to New Delhi Metallo-β-Lactamase-producing E. coli strains. Further research is needed to explore the interaction between different resistance mechanisms and additional factors influencing antibiotic susceptibility. —Antibiotic resistance among Enterobacterales sp., is on the rise. Although all efforts to combat against multi-drug resistant Enterobacterales have been taken, treatment options have been limited. Therefore, a safe and efficient therapy is needed. In this regard, the study aimed to assess the effectiveness of aztreonam, aztreonam-avibactam, cefiderocol, and cefiderocol-avibactam against New Delhi Metallo-β-Lactamase producing E. coli , and to compare their in vitro activity against extended-spectrum β-lactamases (ESBL), AmpC β-lactamases, and metallo-β-lactamases (MBL)-producing E. coli isolates. A total of 57 NDM-producing E. coli isolates were tested using broth microdilution according to EUCAST guidelines. Minimum inhibitory concentrations were determined for each antibiotic. Molecular typing via Multilocus Sequence Typing was performed to identify molecular types. Results showed that aztreonam-avibactam exhibited superior in vitro activity compared to aztreonam, cefiderocol, and cefiderocol-avibactam against ESBLs, AmpCs, and MBLs-producing E. coli isolates. Aztreonam-avibactam demonstrated the best efficacy against NDM-producing E. coli isolates, suggesting its potential in overcoming resistance mechanisms observed with other antibiotics. This study provides valuable insights into the treatment of infections caused by NDM-producing strains and underscores the need for further research to elucidate interactions between different resistance mechanisms and additional factors influencing antibiotic susceptibility.

Deciphering the Efficacy of the β-Lactams in the Face of Metallo-β-lactamase Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth is the Culprit

In vitro Effect of the Combination of Aztreonam and Amoxicillin/Clavulanic Acid Against Carbapenem-Resistant Gram-Negative Organisms Producing Metallo--Lactamase

Characterization of Metallo β-Lactamase Producing Enterobacterales Isolates with Susceptibility to the Aztreonam/Avibactam Combination

Maximally precise combinations to overcome metallo-β-lactamase-producing Klebsiella pneumoniae

In Vitro Activity of Aztreonam-Avibactam Against Metallo--lactamase-producing Enterobacteriaceae-A Multicenter Study in China

Influence of β-lactam pharmacodynamics on the systems microbiology of gram-positive and gram-negative polymicrobial communities

Addressing the Global Threat of Multidrug-Resistant Infections: The Role of Ceftazidime-Avibactam Revisited

The Effectiveness of Aztreonam, Aztreonam-Avibactam, Cefiderocol on blaNDM-Producing E. coli Isolates

Analysis of Antimicrobial Resistance and Detection of Metallo-Β-lactamase in Clinical Isolates of Gram-Negative Bacilli

Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination Against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia Coli and Klebsiella Pneumoniae

Klebsiella Pneumoniae Expressing VIM-1 Metallo-β-Lactamase is Resensitized to Cefotaxime Via Thiol-Mediated Zinc Chelation

Current Strategy for Targeting Metallo-β-Lactamase with Metal-Ion-Binding Inhibitors

Evaluation of gradient strip diffusion for susceptibility testing of aztreonam–avibactam in metallo-β-lactamase-producing Enterobacterales

Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity

Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area

The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases

Aztreonam/avibactam Effect on Pharmacodynamic Indices for Mutant Selection of Escherichia Coli and Klebsiella Pneumoniae Harbouring Serine- and New Delhi Metallo-Β-lactamases.

Comparison of combined disc synergy test and double disc synergy test for phenotypic detection of metallo-ß-lactamase among the clinical isolates of gram-negative bacilli

Modulating the transcriptomic profile of multidrug-resistant Klebsiella pneumoniae biofilm formation by antibiotics in combination with zinc sulfate

The Challenge of Treating Infections Caused by Metallo‐β‐Lactamase–Producing Gram-Negative Bacteria: A Narrative Review

Discerning the role of polymyxin B nonapeptide in restoring the antibacterial activity of azithromycin against antibiotic-resistant Escherichia coli